Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Towards evidence-based immunology

Immunology is in an unprecedented era of exciting exploration, made possible by powerful new tools and technologies. To capitalize on this progress and translate discovery to meaningful impact, a parallel culture of ‘evidence-based immunology’ must be developed.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The spectrum of research development in immunology, from exploration to actionable evidence.

References

  1. Cobey, K. D. et al. PLoS Biol. 22, e3002870 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Baker, M. Nature 533, 452–454 (2016).

    Article  CAS  PubMed  Google Scholar 

  3. Suliman, S., Maison, D. P. & Henrich, T. J. Nat. Immunol. 25, 1765–1769 (2024).

    Article  CAS  PubMed  Google Scholar 

  4. Espin, E. et al. EBioMedicine 91, 104552 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kimmelman, J., Mogil, J. S. & Dirnagl, U. PLoS Biol 12, e1001863 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Holder, A. M. et al. Nat. Rev. Cancer 24, 498–512 (2024).

    Article  CAS  PubMed  Google Scholar 

  7. Guyatt, G. H. et al. BMJ 336, 924–926 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kerr, N. L. Pers. Soc. Psychol. Rev. 2, 196–217 (1998).

    Article  CAS  PubMed  Google Scholar 

  9. Kalimuddin, S. et al. Front. Immunol. 14, 1135979 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kalimuddin, S. et al. Nat. Microbiol. 10, 374–387 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Smith, R. & Rennie, D. BMJ 348, g371 (2014).

    Article  PubMed  Google Scholar 

  12. BIH Quest. Guidance for Planning and Conducting Confirmatory Preclinical Studies and Systematic Reviews (2022).

  13. CAMARADES Berlin. Preclinical Systematic Review Wiki (17 March 2025).

  14. Hooijmans, C. R. et al. BMC Med. Res. Methodol. 14, 43 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Percie du Sert, N. et al. PLoS Biol. 18, e3000411 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank R. Thiebaut and F. Luciani for helpful comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miles P. Davenport.

Ethics declarations

Competing interests

M.P.D. and T.T. are co-leads of the Framework for Evidence Evaluation in Vaccine Assessment (FEEVA) initiative. The other authors have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khoury, D.S., Cromer, D., Bailey, B. et al. Towards evidence-based immunology. Nat Immunol 26, 980–982 (2025). https://doi.org/10.1038/s41590-025-02180-0

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41590-025-02180-0

This article is cited by

Search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology